MYDOCALM

This brand name is authorized in Estonia, Germany, Hong Kong SAR China, Lithuania, Poland, Romania.

Active ingredients

The drug MYDOCALM contains one active pharmaceutical ingredient (API):

1	Tolperisone UNII 8Z075K2TIG - TOLPERISONE HYDROCHLORIDE
	As a skeletal muscle relaxant whose prototype is mephenesine, tolperisone induces ataxia and muscle weakness in animal models by acting on the central nervous system at the spinal level. In fact it inhibits polysynaptic and monosynaptic reflexes with little action on non-reflex muscle response and without potentiating the phenobarbital sleep.
	Read more about Tolperisone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M03BX04	Tolperisone	M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BX Other centrally acting agents
Discover more medicines within M03BX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	04812367, 04812373, 06558849, 06558861, 10545396, 10545404, 10628343, 10628366, 12309004, 16804404
EE	Ravimiamet	1088085, 1088096
HK	Department of Health Drug Office	43895
LT	Valstybinė vaistų kontrolės tarnyba	1012295, 1012302, 1067685, 1080550, 1080551
PL	Rejestru Produktów Leczniczych	100045063, 100045070, 100096600, 100255168, 100257084, 100261513, 100261536, 100269555, 100269561, 100288682, 100304062, 100324099, 100338546, 100370248, 100370277, 100424375, 100458031
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W54832001, W54833001, W54833002